ARMATA PHARMACEUTICALS, INC. — Income Charts
1 quarters of history · ending 2020-06-30 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue
$31K
R&D
$3M
D&A
$300K
Operating Income
$-5M
EBITDA
$-4M
Interest Expense
$142K
Interest Income
$22K
Other Income/Expense
—
Pretax Income
—
Tax Provision
—
Net Income
$-5M
Operating Margin
-14806.5%
Net Margin
-15193.5%
Effective Tax Rate
—
Deferred Tax Liabilities
$0
ETR (Continuing Operations)
—
ETR Federal Statutory
—
ETR State + Local (pp)
—
ETR Foreign Differential (pp)
—
Operating Lease Cost
—
Income YoY Variation
11.0%
Income QoQ Variation
6.7%